|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0001072,
umls-concept:C0008377,
umls-concept:C0018017,
umls-concept:C0023779,
umls-concept:C0025424,
umls-concept:C0087111,
umls-concept:C0301630,
umls-concept:C0360714,
umls-concept:C0965129,
umls-concept:C1280500,
umls-concept:C1546459,
umls-concept:C1704419,
umls-concept:C2603343
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2004-4-12
|
|
pubmed:abstractText |
In a multinational trial (4522IL/0081), we assessed the effects of switching to low doses of rosuvastatin from commonly used doses of atorvastatin, simvastatin, and pravastatin on low-density lipoprotein cholesterol (LDL-C) goal achievement in high-risk patients.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Cholesterol,
http://linkedlifedata.com/resource/pubmed/chemical/Cholesterol, HDL,
http://linkedlifedata.com/resource/pubmed/chemical/Cholesterol, LDL,
http://linkedlifedata.com/resource/pubmed/chemical/Fluorobenzenes,
http://linkedlifedata.com/resource/pubmed/chemical/Heptanoic Acids,
http://linkedlifedata.com/resource/pubmed/chemical/Hydroxymethylglutaryl-CoA...,
http://linkedlifedata.com/resource/pubmed/chemical/Pravastatin,
http://linkedlifedata.com/resource/pubmed/chemical/Pyrimidines,
http://linkedlifedata.com/resource/pubmed/chemical/Pyrroles,
http://linkedlifedata.com/resource/pubmed/chemical/Simvastatin,
http://linkedlifedata.com/resource/pubmed/chemical/Sulfonamides,
http://linkedlifedata.com/resource/pubmed/chemical/Triglycerides,
http://linkedlifedata.com/resource/pubmed/chemical/atorvastatin,
http://linkedlifedata.com/resource/pubmed/chemical/rosuvastatin
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
1097-6744
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
147
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
705-13
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:15077101-Aged,
pubmed-meshheading:15077101-Arteriosclerosis,
pubmed-meshheading:15077101-Cholesterol,
pubmed-meshheading:15077101-Cholesterol, HDL,
pubmed-meshheading:15077101-Cholesterol, LDL,
pubmed-meshheading:15077101-Coronary Disease,
pubmed-meshheading:15077101-Diabetes Mellitus, Type 2,
pubmed-meshheading:15077101-Female,
pubmed-meshheading:15077101-Fluorobenzenes,
pubmed-meshheading:15077101-Heptanoic Acids,
pubmed-meshheading:15077101-Humans,
pubmed-meshheading:15077101-Hydroxymethylglutaryl-CoA Reductase Inhibitors,
pubmed-meshheading:15077101-Hypercholesterolemia,
pubmed-meshheading:15077101-Logistic Models,
pubmed-meshheading:15077101-Male,
pubmed-meshheading:15077101-Middle Aged,
pubmed-meshheading:15077101-Pravastatin,
pubmed-meshheading:15077101-Pyrimidines,
pubmed-meshheading:15077101-Pyrroles,
pubmed-meshheading:15077101-Simvastatin,
pubmed-meshheading:15077101-Sulfonamides,
pubmed-meshheading:15077101-Triglycerides
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
Effects of switching statins on achievement of lipid goals: Measuring Effective Reductions in Cholesterol Using Rosuvastatin Therapy (MERCURY I) study.
|
|
pubmed:affiliation |
Humboldt University, Berlin, Germany. herbert.schuster@infogen.de
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
